Pediatric Dermatology

Pediatric Parvovirus B19: Spectrum of Clinical Manifestations

Parvovirus B19 (PVB19) infection has a varied spectrum of clinical manifestations, ranging from subclinical infection to skin and joint symptoms to hematologic effects with potential fatality. The most common manifestation of PVB19 infection in children is erythema infectiosum (EI). Also known as fifth disease or slapped cheek syndrome, EI presents as an erythematous exanthem limited to the malar eminences that follows a mild prodromal illness. In healthy children, infection is self-limiting and has an excellent prognosis; however, in high-risk pediatric groups (eg, immunocompromised patients, children with hemolytic anemia or prenatal infection), clinical manifestations are hematologic in nature and typically are more severe. Diagnosis often is made clinically. Serologic testing can be confirmatory. Treatment is aimed at symptomatic relief, and a vaccine currently is under investigation.

Test your knowledge on pediatric parvovirus with MD-IQ: the medical intelligence quiz. Click here to answer 5 questions.


 

Recommended Reading

M. genitalium demands new STI treatment strategy
MDedge Dermatology
Biweekly 5-fluorouracil cream beat back cervical neoplasia
MDedge Dermatology
Dexamethasone improves outcomes for infants with bronchiolitis, atopy history
MDedge Dermatology
Stats show MRSA declining, especially in hospitals
MDedge Dermatology
Antibiotic-related illness in U.S. tops 2 million annually
MDedge Dermatology
‘Eczema coxsackium’ cutaneous eruptions characterized
MDedge Dermatology
Flu outlook 2013-2014: Don’t hesitate. Vaccinate!
MDedge Dermatology
Varicella-Zoster Virus in Pregnancy
MDedge Dermatology
Recurrent otitis may be linked to neonate-like immune response in young children
MDedge Dermatology
What Is Your Diagnosis? Hansen Disease (Leprosy)
MDedge Dermatology

Related Articles